Joslyn Sciacca Kirby, MD, MEd, MS

    • 660 Citations
    • 14 h-Index
    If you made any changes in Pure, your changes will be visible here soon.

    Personal profile

    Research interests

    Dr. Joslyn Kirby is a dermatologist and physician-scientist whose research has focused on value, including variation in care, costs, and outcomes, and hidradenitis suppurativa.

    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a large negative effect on quality of life. Dr. Kirby's research related to HS included health services research of utilization and costs, coping and resilience and research of novel outcome measures.

    Dr. Kirby has been an investigator on several clinical trials, both industry-sponsored and investigator-initiated. She also utilized mixed methods in educational research and developed a novel workplace-based evaluation tool to support resident and student evaluation. She also worked to design and implement a clinical decision support app for prescribing topical corticosteroids (the CorticoCream Calculator, available in the iTunes and Play stores).

    Teaching and educational interests

    Dr. Joslyn Kirby, who is the Vice Chair for Education for the Department of Dermatology, is an active educator at all levels of medical education. She is the course director for dermatology education for pre-clinical medical students, oversees the clerkship for the clinical dermatology elective, is the program director for the dermatology residency, and is an active speaker at numerous national and international medical educational meetings.

    Education/Academic qualification

    MEd, The Pennsylvania State University

    … → May 2015

    Public Health Sciences, MS, The Pennsylvania State University

    … → Dec 2014

    Dermatology, Residency, University of Pennsylvania

    … → Jun 2008

    Preliminary Year in Internal Medicine, Pennsylvania Hospital

    … → Jun 2005

    MD, University of Virginia

    … → May 2004

    Fingerprint Dive into the research topics where Joslyn Sciacca Kirby is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 5 Similar Profiles
    Hidradenitis Suppurativa Medicine & Life Sciences
    Actinic Keratosis Medicine & Life Sciences
    Costs and Cost Analysis Medicine & Life Sciences
    Dermatology Medicine & Life Sciences
    Acne Vulgaris Medicine & Life Sciences
    Teaching Rounds Medicine & Life Sciences
    Quality of Life Medicine & Life Sciences
    Skin Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 2016 2020

    Hidradenitis Suppurativa
    Outcome Assessment (Health Care)
    Reproducibility of Results
    social media
    research project

    Research Output 2004 2020

    3 Citations (Scopus)

    A narrative review of the definition of ‘flare’ in hidradenitis suppurativa

    Kirby, J. S., Moore, B., Leiphart, P., Shumaker, K., Mammis-Gierbolini, A., Benhadou, F. & del Marmol, V., Jan 1 2020, In : British Journal of Dermatology. 182, 1, p. 24-28 5 p.

    Research output: Contribution to journalReview article

    Hidradenitis Suppurativa
    Clinical Trials
    3 Citations (Scopus)

    Periodic worsening, or flare, in hidradenitis suppurativa: the perspective of people with hidradenitis

    Sarfo, A., Butt, M. & Kirby, J. S., Jan 1 2020, In : British Journal of Dermatology. 182, 1, p. 218-219 2 p.

    Research output: Contribution to journalLetter

    Hidradenitis Suppurativa

    Adherence to Over-the-Counter Antimicrobial Washes in Hidradenitis Suppurativa Patients

    Leiphart, P., Kitts, S. & Sciacca Kirby, J., Aug 1 2019, In : Dermatology. 235, 5, p. 440-441 2 p.

    Research output: Contribution to journalLetter

    Open Access
    Hidradenitis Suppurativa

    Assessment of Overpayment for Topical Dermatological Drugs - Clawbacks

    Shumaker, K., MacZuga, S. & Kirby, J., Nov 2019, In : JAMA Dermatology. 155, 11, p. 1315-1317 3 p.

    Research output: Contribution to journalLetter

    Pharmaceutical Preparations
    Actinic Keratosis
    Costs and Cost Analysis
    Quality of Health Care
    International Classification of Diseases